Xuxi Zhang

Systolic: 129.9±15.6 Diastolic: 73.6±10.0 Total Cholesterol (mg/dl): LDL: 94.9±30.4 HDL: 38.2±7.4 BMI: 32.0±5.4 Without diabetic retinopathy (%): 54.9 Systolic: 129.4±16.8 Diastolic: 73.2±10.5 Total Cholesterol (mg/dl): LDL: 96.4±29.8 HDL: 38.9±7.6 BMI: 32.6±5.3 Without diabetic retinopathy (%): 52.6 ADVANCE, 2008 Baseline: IG: 5571 CG: 5569 Follow ‐ up (median: 5 years): IG: 4828 CG: 4741 Patients with type 2 diabetes Female (%):42.6 Mean age: 66±6 Duration of diabetes (year): 7.9±6.3 HbA1c (%): 7.51±1.57 Blood pressure (mm Hg): Systolic: 145.0±21.7 Diastolic: 80.8±11.0 Total Cholesterol (mmol/l): LDL: 3.12±1.04 HDL: 1.26±0.35 BMI: 28±5 Without diabetic retinopathy (%):  ‐  Patients with type 2 diabetes Female (%):42.3 Mean age: 66±6 Duration of diabetes (year): 8.0±6.4 HbA1c (%): 7.52±1.54 Blood pressure (mm Hg): Systolic: 145.0±21.4 Diastolic: 80.5±10.8 Total Cholesterol (mg/dl): LDL: 3.11±1.02 HDL: 1.25±0.35 BMI: 28±5 Without diabetic retinopathy (%): ‐  RCT Asia, Australasia, Europe, and North America Glycemic ‐ control intervention Intensive blood glucose control (target HbA1c value, ≤ 6.5%) vs. Standard glucose control AdRem Study @ , 2009 Baseline: IG: 791 CG: 811 Follow ‐ up (4.1 years): IG: 630 CG: 611 Patients with type 2 diabetes Female (%): 38.1 Mean age: 65.6±6.0 Duration of diabetes: 6 (IQR 2 ‐ 11) HbA1c (%):7.4±1.5 Blood pressure (mm Hg): Systolic: 142.7±22.2 Diastolic: 79.6±10.9 Total Cholesterol (mmol/l): LDL:  ‐  HDL:  ‐  BMI:  ‐  Without diabetic retinopathy (%): 49.7 Patients with type 2 diabetes Female (%): 39.3 Mean age: 65.6±5.7 Duration of diabetes: 6 (IQR 2 ‐ 11) HbA1c (%): 7.4±1.5 Blood pressure (mm Hg): Systolic: 142.7±21.2 Diastolic: 79.0±10.8 Total Cholesterol (mmol/l): LDL:  ‐  HDL:  ‐  BMI:  ‐  Without diabetic retinopathy (%): 51.3 RCT Asia, Australasia, Europe, and North America Glycemic ‐ control intervention Intensive blood glucose control (target HbA1c value, ≤ 6.5%) vs. Standard glucose control 7 187 Prevention and control of diabetic retinopathy